Back to JACOBS LEVY EQUITY MANAGEMENT, INC JACOBS LEVY EQUITY MANAGEMENT, INC

TXGTXG
Showing 8 of 10 quarters

Position history for JACOBS LEVY EQUITY MANAGEMENT, INCJACOBS LEVY EQUITY MANAGEMENT, INC's holdings in 10X GENOMICS INC

Yes. Jacobs Levy Equity Management holds 2,019,883 shares of TXG (10X Genomics), worth $77.4M, as of its Q2 2026 13F filing. It reduced the position by 263,541 shares (-11.5%) from Q1 2026. Jacobs Levy Equity Management has held TXG since Q4 2024, across 7 quarterly 13F filings. TXG is 0.3% of Jacobs Levy Equity Management's reported 13F portfolio.

Current Value

$77.4M

Current Shares

2M

Total Value Change

+$77.4M

Total Shares Change

+2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
2M
-11.5%
$77.4M0.3%$38.34
0
2026-Q1
Decreased
2.3M
-13.5%
$48.5M0.2%$22.62
0
2025-Q4
Decreased
2.6M
-10.4%
$43.1M0.2%$16.29
0
2025-Q3
Increased
2.9M
+22.9%
$34.5M0.1%$11.34
42
2025-Q2
Increased
2.4M
+105.5%
$27.8M0.1%$11.73
55
2025-Q1
Increased
1.2M
+3619.6%
$10.2M0.0%$9.16
45
2024-Q4
New
31,367
-
$450,4300.0%$14.35
33
2024-Q3
Exited
0
-100.0%
$00.0%$22.67
0

Other major holders of TXG: FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used